Logo image of GLRE

GREENLIGHT CAPITAL RE LTD-A (GLRE) Stock Fundamental Analysis

NASDAQ:GLRE - Nasdaq - KYG4095J1094 - Common Stock - Currency: USD

14.32  +0.17 (+1.2%)

After market: 14.32 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to GLRE. GLRE was compared to 144 industry peers in the Insurance industry. The financial health of GLRE is average, but there are quite some concerns on its profitability. GLRE is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

GLRE had positive earnings in the past year.
GLRE had a positive operating cash flow in the past year.
In the past 5 years GLRE has always been profitable.
In multiple years GLRE reported negative operating cash flow during the last 5 years.
GLRE Yearly Net Income VS EBIT VS OCF VS FCFGLRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

GLRE has a Return On Assets of 2.14%. This is comparable to the rest of the industry: GLRE outperforms 52.78% of its industry peers.
GLRE has a Return On Equity of 6.89%. This is in the lower half of the industry: GLRE underperforms 71.53% of its industry peers.
Industry RankSector Rank
ROA 2.14%
ROE 6.89%
ROIC N/A
ROA(3y)2.92%
ROA(5y)2.05%
ROE(3y)8.8%
ROE(5y)6.19%
ROIC(3y)N/A
ROIC(5y)N/A
GLRE Yearly ROA, ROE, ROICGLRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

GLRE has a Profit Margin of 6.85%. This is comparable to the rest of the industry: GLRE outperforms 45.83% of its industry peers.
In the last couple of years the Profit Margin of GLRE has grown nicely.
With a Operating Margin value of 1.29%, GLRE is not doing good in the industry: 82.64% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of GLRE has declined.
Industry RankSector Rank
OM 1.29%
PM (TTM) 6.85%
GM N/A
OM growth 3Y-37.65%
OM growth 5YN/A
PM growth 3Y30.1%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GLRE Yearly Profit, Operating, Gross MarginsGLRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

GLRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GLRE remains at a similar level compared to 1 year ago.
The number of shares outstanding for GLRE has been reduced compared to 5 years ago.
The debt/assets ratio for GLRE has been reduced compared to a year ago.
GLRE Yearly Shares OutstandingGLRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
GLRE Yearly Total Debt VS Total AssetsGLRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

GLRE has a debt to FCF ratio of 0.58. This is a very positive value and a sign of high solvency as it would only need 0.58 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 0.58, GLRE is doing good in the industry, outperforming 77.78% of the companies in the same industry.
A Debt/Equity ratio of 0.09 indicates that GLRE is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.09, GLRE is doing good in the industry, outperforming 79.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.58
Altman-Z N/A
ROIC/WACCN/A
WACC8.65%
GLRE Yearly LT Debt VS Equity VS FCFGLRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
GLRE Yearly Current Assets VS Current LiabilitesGLRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

GLRE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.86%.
The Earnings Per Share has been growing by 34.26% on average over the past years. This is a very strong growth
GLRE shows a small growth in Revenue. In the last year, the Revenue has grown by 2.65%.
The Revenue has been growing slightly by 4.45% on average over the past years.
EPS 1Y (TTM)-56.86%
EPS 3Y34.26%
EPS 5YN/A
EPS Q2Q%10.26%
Revenue 1Y (TTM)2.65%
Revenue growth 3Y3.53%
Revenue growth 5Y4.45%
Sales Q2Q%-3.36%

3.2 Future

The Earnings Per Share is expected to grow by 16.14% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y34.88%
EPS Next 2Y16.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLRE Yearly Revenue VS EstimatesGLRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
GLRE Yearly EPS VS EstimatesGLRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6 -8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

GLRE is valuated reasonably with a Price/Earnings ratio of 11.10.
Compared to the rest of the industry, the Price/Earnings ratio of GLRE indicates a somewhat cheap valuation: GLRE is cheaper than 60.42% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of GLRE to the average of the S&P500 Index (27.45), we can say GLRE is valued rather cheaply.
A Price/Forward Earnings ratio of 8.77 indicates a reasonable valuation of GLRE.
65.28% of the companies in the same industry are more expensive than GLRE, based on the Price/Forward Earnings ratio.
GLRE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.90.
Industry RankSector Rank
PE 11.1
Fwd PE 8.77
GLRE Price Earnings VS Forward Price EarningsGLRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, GLRE is valued a bit cheaper than 70.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.81
EV/EBITDA N/A
GLRE Per share dataGLRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GLRE's earnings are expected to grow with 16.14% in the coming years.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y16.14%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GLRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENLIGHT CAPITAL RE LTD-A

NASDAQ:GLRE (7/3/2025, 7:31:47 PM)

After market: 14.32 0 (0%)

14.32

+0.17 (+1.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04
Inst Owners49.72%
Inst Owner Change3.99%
Ins Owners24.36%
Ins Owner Change-0.37%
Market Cap494.90M
Analysts43.33
Price TargetN/A
Short Float %0.87%
Short Ratio1.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1900.98%
Min EPS beat(2)-3870.59%
Max EPS beat(2)68.63%
EPS beat(4)2
Avg EPS beat(4)-939.86%
Min EPS beat(4)-3870.59%
Max EPS beat(4)68.63%
EPS beat(8)5
Avg EPS beat(8)-435.43%
EPS beat(12)7
Avg EPS beat(12)-367.94%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.1
Fwd PE 8.77
P/S 0.74
P/FCF 4.81
P/OCF 4.76
P/B 0.74
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)1.29
EY9.01%
EPS(NY)1.63
Fwd EY11.4%
FCF(TTM)2.98
FCFY20.8%
OCF(TTM)3.01
OCFY21.01%
SpS19.42
BVpS19.3
TBVpS19.3
PEG (NY)0.32
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.14%
ROE 6.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 1.29%
PM (TTM) 6.85%
GM N/A
FCFM 15.34%
ROA(3y)2.92%
ROA(5y)2.05%
ROE(3y)8.8%
ROE(5y)6.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-37.65%
OM growth 5YN/A
PM growth 3Y30.1%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.58
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.79
Cash Conversion N/A
Profit Quality 223.86%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC8.65%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.86%
EPS 3Y34.26%
EPS 5YN/A
EPS Q2Q%10.26%
EPS Next Y34.88%
EPS Next 2Y16.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.65%
Revenue growth 3Y3.53%
Revenue growth 5Y4.45%
Sales Q2Q%-3.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-88.61%
EBIT growth 3Y-35.45%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y580.08%
FCF growth 3YN/A
FCF growth 5Y132.58%
OCF growth 1Y585.08%
OCF growth 3YN/A
OCF growth 5Y133.03%